The abstract is read at the publisher; the summary is JClub's.
Chronic hepatitis B virus infection is largely restricted to humans and chimpanzees, limiting in vivo models despite progress in identifying host and viral determinants of species specificity.
- Why it matters: The narrow host range blocks experimentally tractable systems needed to study viral persistence, pathogenesis, and immune control, slowing development of curative strategies for chronic hepatitis B.
- What they did: The field has advanced using genetically engineered systems, surrogate hepadnaviruses that infect other species, and humanized liver models that allow infection in vivo within a human hepatocyte context.
- The result: No available model fully recapitulates chronic HBV infection in an immunocompetent host, so defining and overcoming host-range barriers remains central for physiologically relevant models and cure development.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.